McCann NC, et al. - Researchers aimed at inscribing costs of recommended initial antiretroviral treatment (ART) regimens in the United States from 2012 to 2018 and the magnitude of cost changes over time. Compared with all other well-resourced countries, including Britain, Australia, and Canada, the highest antiretroviral treatment (ART) prices yet the lowest rate of HIV viral suppression (54%) were reported in the United States. Among many structural barriers, high ART costs may result in poor treatment access and adherence, contributing to suboptimal HIV outcomes in the United States.